Breaking News

Investigation: Medicare Advantage algorithm sparks dissent; why maternal mortality is so hard to measure

July 11, 2023
Eros Dervishi for STAT

STAT+ | How UnitedHealth's acquisition of a popular Medicare Advantage algorithm sparked internal dissent over denied care

An investigation of UnitedHealth Group's NaviHealth reveals its algorithm is a focal point for determining Medicare Advantage coverage.

By Casey Ross and Bob Herman


Why maternal mortality is so hard to measure — and why the problem may get worse

Maternal mortality data collection is inconsistent across states, and the findings of mortality review committees have been politicized.

By Annalisa Merelli


Takeda withdraws application for dengue vaccine from FDA

The company said in a press release that it will review whether to proceed with trying to bring the dengue vaccine to the U.S. market.

By Helen Branswell



NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants?
Lydia Polimeni/NIH

STAT+ | NIH fellows, weighing a union, want a pay raise. Will that mean less money for grants?

NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants?

By Brittany Trang


White House announces new plan to address the growing threat of xylazine in overdose crisis

The White House unveiled a plan to address the growing presence of xylazine, a veterinary tranquilizer, in the country's illicit drug supply. 

By Lev Facher


STAT+ | Eisai executive who helped lead development of Alzheimer's drug to retire

Ivan Cheung will be replaced in his capacity as head of the company's Alzheimer's unit by Keisuke Naito, son of the company's CEO.

By Brittany Trang


Adobe

A new study of sick infants sees potential in DNA sequencing, but also a need for better ways to interpret the genome

But the study also found that labs often interpreted genetic information differently, despite working with identical patient samples.

By Jonathan Wosen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments